Evidence map›Paper›PMID 42793276›Full record

ArticleCurrent issues in molecular biology2026

Antidepressant Effects of 20-Glucoginsenoside Rf in an L-AAA-Induced Mouse Model with Glial-Associated Molecular Alterations.

Sangbeom Kim, Seung-Hun Cho

Abstract read
PubMed Publisher
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sangbeom KimDepartment of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Seung-Hun ChoDepartment of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.ORCID 0000-0002-0627-768X

Funding

National Research Foundation of Korea RS-2025-23323387
6 · The paper itself

Abstract

Major depressive disorder (MDD) is a leading contributor to disability worldwide, yet current antidepressant treatments remain limited by incomplete remission, treatment resistance, and adverse effects. 20-glucoginsenoside Rf (20-gluco-Rf), a trace bioactive saponin derived from

Indexed as

20-glucoginsenoside Rfastrocyteglial fibrillary acidic protein (GFAP)L-alpha-aminoadipic acidmajor depressive disorder

Identifiers

PMID42793276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.